A chilling new CCTV video from the Delhi Red Fort blast has surfaced, showing the exact moment when a white i20 car exploded in the middle of evening traffic at 6:52 PM. The blast turned the vehicle ...

Painstaking experiments have revealed the cellular signatures that signify a tuberculosis infection, providing a series of targets for new vaccines that could finally subdue one of the world’s leading ...

Ford is considering scrapping the electric version of its F-150 pickup — once billed as the future of American trucks — after racking up billions in losses and watching demand collapse. Executives are ...

The Defence Headquarters (DHQ) in Nigeria has detained 16 senior officers for what it described as “indiscipline and breach of service regulations”, and rejected claims of a failed coup. The arrests ...

Elon Musk confirmed over the weekend reports that Tesla has disbanded the team working on its Dojo AI training supercomputer, just weeks after announcing he expected to have Tesla’s second cluster ...

The Freeport City Council voted out its city manager Wednesday night, after a recording surfaced of him allegedly threatening to kill a council member in the Brazoria County community of nearly 11,000 ...

Software King of the World Microsoft has quietly booted the 256GB versions of last year’s 13.8-inch Surface Laptop 7 and 13-inch Surface Pro 11 off its store, leaving only pricier 512GB and 1TB ...

A version of this story appeared in the daily Threat Status newsletter from The Washington Times. Click here to receive Threat Status delivered directly to your inbox each weekday. Google has taken an ...

Apple TV+’s Surface finally returns for a second season on February 21, 2025. The first season debuted way back in July 2022 so you’re forgiven if you forgot a second season was even on the way. New ...

Blues legend Charlie Musselwhite has signed with Forty Below Records, and announced a forthcoming release this spring. Tomorrow, January 10, Musselwhite will preview his latest project with a single, ...

PharmaEssentia is looking to expand the reach of its FDA-approved rare blood cancer treatment Besremi to another rare blood disorder after reviewing encouraging results from a phase 3 study. In the ...